FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to an agent for intraarticular administration. Agent for intraarticular administration for medical use contains hyaluronic acid or sodium hyaluronate, glucosamine or glucosamine sulphate or glucosamine hydrochloride, 10 mg/ml of vitamin C and a zinc salt. What is also disclosed is the use of the agent for treating a certain group of diseases and conditions and the use of vitamin C for preparing the agent for intraarticular administration.
EFFECT: disclosed is a combined agent for intraarticular administration.
16 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
AGENT FOR TREATMENT OF INFLAMMATORY AND DEGENERATIVE JOINT DISEASE (VARIANTS), METHOD FOR TREATMENT OF INFLAMMATORY AND DEGENERATIVE JOINT DISEASE (VARIANTS) AND DEVICE FOR DELIVERY OF MEDICINAL AGENT TO DAMAGED SITE | 2004 |
|
RU2268052C2 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
COMBINATION FOR TREATING OSTEOARTHRITIS | 2010 |
|
RU2560844C2 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OSTEOARTHRITIS, CONTAINING CLODRONIC ACID AND HYALURONIC ACID | 2006 |
|
RU2414908C2 |
SYNOVIAL FLUID PROSTHESIS AND ITS PRODUCTION METHOD | 2021 |
|
RU2782921C1 |
METHOD FOR TREATMENT OF JOINT DISEASES | 2021 |
|
RU2777213C1 |
INTRA-ARTICULAR FLUID SIMULATOR FORMULATION AND METHOD FOR PREPARING INTRA-ARTICULAR FLUID ADDITIVE | 2011 |
|
RU2473352C2 |
INJECTION COMPOSITION OF POLYDEOXYRIBONUCLEOTIDES FOR TREATING OSTEOARTICULAR DISEASES | 2009 |
|
RU2508115C2 |
Authors
Dates
2020-11-27—Published
2017-04-24—Filed